Delaware
|
001-38613
|
26-1756290
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
9540 Towne Centre Drive,
Suite 100
San Diego,
California
|
|
92121
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share
|
BNGO
|
The Nasdaq Stock Market LLC
|
Warrants to purchase Common Stock
|
BNGOW
|
The Nasdaq Stock Market LLC
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d) |
Exhibits
|
Exhibit
No.
|
Exhibit Title or Description
|
Opinion of Cooley LLP.
|
|
104
|
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)
|
|
Bionano Genomics, Inc.
|
|
|
|
|
Date: November 24, 2023
|
By:
|
/s/ R. Erik Holmlin, Ph.D.
|
|
|
R. Erik Holmlin, Ph.D.
|
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
November 24, 2023
Page Two
|
Cooley LLP
|
||
|
||
By:
|
/s/ Thomas A. Coll
|
|
|
Thomas A. Coll
|
|